🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary 1\. To determine the pharmacokinetic (PK) parameters of rasburicas...
Status
Completed
Location
The University of Texas M.D. Anderson Cancer Center
Start Date
2006-07
Trial ID
NCT00360438
Treatments Being Tested
The purpose of this Phase IIa study is to evaluate the safety and tolerabil...
Status
Completed
Location
Celerion
Start Date
2021-07-16
Trial ID
NCT04987242
This is an open-label, multi-center study with 2 arms. The primary objectiv...
Status
Completed
Location
Alta Bates Comprehensive Cancer Center
Start Date
2004-03
Trial ID
NCT00230217
Treatments Being Tested
The purpose of this study is to determine whether PEG-uricase (a chemically...
Status
Completed
Location
Duke University Medical Center
Start Date
2004-12
Trial ID
NCT00111657
Treatments Being Tested
RATIONALE: Rasburicase may be an effective treatment for graft-versus-host ...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2008-01
Trial ID
NCT00513474
This is a multi-center trial for rasburicase in children at high risk of tu...
Status
Completed
Location
Stanford University
Start Date
2005-03
Trial ID
NCT00186940
Treatments Being Tested
A randomized, double-blind, placebo-controlled study of tolerance, pharmaco...
Status
Unknown
Location
The Affiliated Hospital of Qingdao University
Start Date
2021-12-08
Trial ID
NCT05226013
Treatments Being Tested
Primary Objective: To evaluate safety of rasburicase in pediatric patients...
Status
Completed
Location
investigational site CHINA
Start Date
2020-05-14
Trial ID
NCT04349306
Treatments Being Tested
The primary objectives of the study are to evaluate the safety and the effi...
Status
Completed
Location
Sanofi-Aventis
Start Date
2003-04
Trial ID
NCT00631579
Treatments Being Tested
Primary Objectives: To determine the efficacy of rasburicase administered ...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2008-01
Trial ID
NCT00628628
Treatments Being Tested